Variant report
Variant | esv2759230 |
---|---|
Chromosome Location | chr4:21172465-21180995 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145267773 | chr4:21175229-21175230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543088614 | chr4:21175312-21175313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79162938 | chr4:21175315-21175316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565759353 | chr4:21175316-21175317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528627870 | chr4:21175343-21175344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547140324 | chr4:21175383-21175384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17513440 | chr4:21175390-21175391 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs550946991 | chr4:21175409-21175410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570381052 | chr4:21175419-21175420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185354673 | chr4:21175481-21175482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190064445 | chr4:21175496-21175497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545727138 | chr4:21175514-21175515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147212377 | chr4:21175542-21175543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533612922 | chr4:21175548-21175549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2162080 | chr4:21175571-21175572 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs201173680 | chr4:21175574-21175575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10516374 | chr4:21175619-21175620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs73247383 | chr4:21175633-21175634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556178575 | chr4:21175641-21175642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4696972 | chr4:21175653-21175654 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs543025143 | chr4:21175662-21175663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561240621 | chr4:21175680-21175681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76110377 | chr4:21175698-21175699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540692182 | chr4:21175740-21175741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565383269 | chr4:21175757-21175758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370737237 | chr4:21175778-21175779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140642308 | chr4:21175780-21175781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551929086 | chr4:21175798-21175799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551196755 | chr4:21175842-21175843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34141805 | chr4:21175844-21175845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569434030 | chr4:21175882-21175883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182758515 | chr4:21175909-21175910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114530939 | chr4:21175937-21175938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548492241 | chr4:21175941-21175942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566096278 | chr4:21175992-21175993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542063492 | chr4:21177000-21177001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560402172 | chr4:21177007-21177008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77070331 | chr4:21177034-21177035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112551009 | chr4:21177048-21177049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189007097 | chr4:21177074-21177075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564297933 | chr4:21177076-21177077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114857302 | chr4:21177146-21177147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564077586 | chr4:21177219-21177220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146873687 | chr4:21177233-21177234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1346050 | chr4:21177255-21177256 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs548096434 | chr4:21177261-21177262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs28691096 | chr4:21177267-21177268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547646516 | chr4:21177334-21177335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565958106 | chr4:21177353-21177354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28459701 | chr4:21177369-21177370 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22737080 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22183965 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21175200-21175800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:21175200-21176000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:21177000-21179200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |